US Department of Health and Human Services Selects Inmar Intelligence for a 5-year Contract to Deliver Pharmaceutical Supply Chain Solutions

Inmar Intelligence, a leading provider of data-driven healthcare technology solutions, today announced it has secured a contract with the US Department of Health and Human Services (HHS) to provide pharmaceutical supply chain solutions across the country.
HealthcarePricingRapidResponseBlog

The Push for Healthcare Price Transparency: Will Pharmacies See a Benefit?

By Jason Murry, Senior Director, Healthcare Sales: Recent passage of the Lower Costs, More Transparency (LCMT) Act in a bipartisan vote by the U.S. House of Representatives is being heralded by the bill’s sponsors as “landmark legislation,” but is it really? The bill -- which is a long way from becoming law -- is focused on the very politically popular issue of lowering prescription drug prices for consumers. But where is the benefit for pharmacies?  
Woman entering credit card information into a mobile device.

What does the future hold for retail media?

Leah Logan: Expect a shift from retail media standardization to transparency.  As brands continue to invest more in retail media, they’re looking for a consistent way to talk about and measure performance across the multiple retail media networks — to determine where to invest their budgets. While both brands and retailers see standardization at some level as a necessary step in the evolution of retail media, more complex metrics will be needed to provide rationale for how one RMN is differentiated from another. 

Inmar's Drug Stewardship Program Gains Preliminary Approval from the Illinois Environmental Protection Agency

Inmar Intelligence, an experienced drug stewardship operator and leader in pharmaceutical reverse distribution, is pleased to announce that the Illinois Environmental Protection Agency (IEPA) granted preliminary approval of its Drug Stewardship program for the State of Illinois on September 26.